Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,297
Sort by:
Global Stem Cell Therapy Market Future Outlook
US$ 2,400.00
... Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication Marketed Stem Cell Therapies ...
July 2015
300 pages
Physician Views: Will Patient Switching Studies Support Biosimilar Adoption?
US$ 695.00
... market will at some point provide a secondary benchmark for biosimilar developers, physicians, patients and payers, when data from a much anticipated 500-patient switching study ... in the EU5 the following questions this week… Has your view towards current/future usage of biosimilar TNF inhibitors become more ...
June 2015
Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020
US$ 1,100.00
... NIFTY tests are also looking to capture maximum pie of the Global NIPT market. Global - Non-Invasive Prenatal Testing (NIPT) Volume Analysis: In the Global NIPT Test Volume, NIFTY Test captured ... “Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020” is a 107 page report with 40 Figures and 13 Table. This report analyses the Global - Non-Invasive Prenatal Testing (NIPT ...
June 2015
107 pages
Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019
US$ 3,955.00
... following pointers: Market Penetration: Comprehensive information on the product portfolios of the top players in the immunoassay market. The report analyzes the immunoassay market by technology, products and services, applications, end user, and region Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities ...
May 2015
298 pages
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars
US$ 750.00
... latest Chinese guidance for development, evaluation, license approval of biosimilars, Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars provided a comprehensive and thorough knowledge of the latest Chinese guidance for development, evaluation, license approval of biosimilars ...
May 2015
48 pages
Global Implantable Biomaterials Market Outlook (2014-2022)
US$ 4,150.00
... and effectiveness of medical implants and its associated procedures. This has contributed considerably to the growth of the biomaterials market. The global implantable biomaterials market is segmented on materials types, applications and region. Depending on the materials type the market is segmented into four ...
April 2015
87 pages
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2020
US$ 3,955.00
... bioinformatics market by sectors, products and services, application and geography. Knowledge management tools accounted for the largest share of the global bioinformatics market ...
April 2015
186 pages
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux
US$ 288.00
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015 ...
March 2015
50 pages
Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab
US$ 346.00
Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated ...
March 2015
62 pages
Global Monoclonal Antibodies Pipeline Insight 2015
US$ 2,400.00
... Antibodies Global Monoclonal Antibodies Market Overview Global Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase Global Monoclonal Antibodies Clinical Pipeline: 1096 mAb Marketed Monoclonal Antibodies: 66 mAb Global Cancer Monoclonal Antibodies Clinical Pipeline: 602 mAb Marketed Cancer ...
March 2015
1600 pages
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin
US$ 390.00
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and ... and make out about 81% of the franchise sale. Therefore, the Her2 antibody market is not only highly attractive for biosimilar developments ...
February 2015
64 pages
Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), And Geography - Forecast Till 2019
US$ 3,955.00
... biocatalysts market is anticipated to show a high growth rate in the coming years. The market is innovation driven and investments are expected for new biocatalysis process ... in future years. Advancement in biocatalysis process along with increasing penetration of biocatalysts in different applications is driving the growth of the global biocatalysts market. Novozymes (Denmark), DuPont ...
February 2015
192 pages
Top 250 Biotechnology (Nordic)
US$ 1,250.00
... report is an in-depth financial evaluation of the Nordic Biotechnology. Using the unique Plimsoll method of analysis, each of the largest 250 companies is individually assessed ... are some of the key findings of this new report: 60 of the 250 companies analysed have been rated as Danger 45 companies are ripe ...
January 2015
355 pages
Top 390 Biotechnology (Pharmaceuticals) (Global)
US$ 1,500.00
... depth financial evaluation of the Global Biotechnology (Pharmaceuticals). Using the unique Plimsoll method of analysis, each of the largest 390 companies is individually assessed ... are some of the key findings of this new report: 197 of the 390 companies analysed have been rated as Danger 167 companies are ...
January 2015
495 pages
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
US$ 6,900.00
... , Spain and Italy, Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders offers insights on how Medical Affairs teams from companies developing and marketing biosimilar anti-TNF monoclonal ... , Spain, the UK; EU5 – biosimilar mAb developers and companies marketing branded mAbs require solid evidence upon which to base medical affairs’ strategy for their ...
January 2015
New Phase of Mab biosimilar knocks the door Biosimilar Opportunities In Japan
US$ 4,000.00
... players (Daiichi-Sankyo, KHK), JP Innovator+ GE companies (Meiji, Fujifilm, Nippon Kayaku, Mochida, and Kissei), Global Multinationals (Pfizer, Sandoz) and some rising star JP local companies (Yoshindo, Gene Techno Science, Sanwa Kagaku ...
January 2015
65 pages
Biopreservation: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen ... forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary ...
January 2015
256 pages
Biosimulation Technology: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Biosimulation Technology in US$ Thousand. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary ...
January 2015
164 pages
Biometrics - A Global Market Overview
US$ 4,500.00
... prices dropping and reliability and convenience going up, the promise offered by biometrics to the world in the diverse ways of managing identities is beyond comprehension ... , Surveillance and Others. The report also analyzes the global Biometrics market for prominent end-use sectors including Government & Civil ...
January 2015
410 pages
Biophotonics: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for Biophotonics in US$ Million by the following End-Use Sectors: Medical (Therapeutics, Diagnostics, & ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
January 2015
307 pages
Fingerprint Biometrics: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for Fingerprint Biometrics in US$ Million by the following Product Segments: Automated FIS, and Non- ... , Inc. Cross Match Technologies, Inc. DERMALOG Identification Systems GmbH Fingerprint Cards AB
January 2015
333 pages
Marine Biotechnology: Market Research Report
US$ 4,950.00
... report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer ...
December 2014
246 pages
U.S. Orthopedic Biomaterials Market
US$ 6,495.00
... stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone. Orthopedic biomaterial ...
December 2014
288 pages
Global Biosimilar Market Trends & Opportunities: 2015 Edition
US$ 800.00
... “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market ... titled “The Global Biosimilar Market: Trends & Opportunities (2014-2018)” provides an in-depth analysis of the growing Biosimilar Market with detailed analysis of market sizing and growth, market share and ...
December 2014
80 pages
Evolution of Technologies for Therapeutic Antibodies-From mAbs to Biosimilars
US$ 1,999.00
The report provides in-depth information on technologicial platforms being developed for monoclonal antibodies and how they have been improvised for biosimilar development. Also various issues pertaining to manufacturing of biosimilars have been highlighted with possible solutions to to address the hurdles.
December 2014
64 pages
Bio-based Materials China News 1412 (12 issues per year)
US$ 2,916.00
... bio-based materials and to make short-term prediction. The above hot topics in China’s bio-based materials market will be explored and reported by CCM in detail in this e-journal, Bio-based Materials China News 1412 ...
December 2014
30 pages
China Biopharmaceuticals Mfg. Industry Data Report
US$ 580.00
This data report provides key statistics and concise analysis on biopharmaceuticals mfg. industry in China. It presents an overview on biopharmaceuticals mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of biopharmaceuticals ...
December 2014
22 pages
Global Nanoparticle Market Outlook 2020
US$ 1,200.00
... with growing applications in various fields. In our latest research report “Global Nanoparticle Market Outlook 2020”, analysts have identified the speedy research and ... the market will grow at a CAGR of 16% during 2015-2020. Our analysts have further identified the major emerging trends and the key challenges ...
November 2014
50 pages
Physician Views: What opportunity for biosimilar basal insulin?
US$ 695.00
... have historically had minimal opportunity to leverage discounts from an oligopolistic ... well established players, it remains to be seen how comfortable physicians would be using a 'biosimilar' insulin developed by ... as 'interchangeable' with branded Lantus). Similarly, what percentage of patients would you be ...
November 2014
Global and China Monoclonal Antibody Industry Report, 2014-2019
US$ 2,600.00
... capacity of domestic monoclonal antibody agents will be further enhanced. With advancement of monoclonal antibody technology, incoming expiry date for patents of some blockbuster monoclonal antibody agents and bright future for monoclonal antibody, Livzon Pharmaceutical Group ...
October 2014
136 pages
Physician Views: Biosimilar Lucentis – what opportunity?
US$ 695.00
... Lucentis, while the availability of compounded Avastin, used as an alternative to Lucentis at a much cheaper cost, adds further confusion to the market outlook. Furthermore, a Physician Views ... therapies persists). FirstWord's Biosimilar Index reveals just one biosimilar Lucentis product in development; PF582 ...
October 2014
Europe Biosimilars Market & Pipeline Insight
US$ 2,400.00
... Europe Biosimilars Market & Pipeline Insight” Report Highlight: Biosimilars Market Overview & Trend Analysis by Country Biosimilars Introduction Timeline in Europe Biosimilars Development & Market Authorization Guidelines Biosimilars Clinical Pipeline by Phase, Indication, Company & Country Marketed ...
October 2014
360 pages
Global Biosimilars Market Regulations & Pipeline Insight
US$ 2,400.00
... biosimilars products being developed owing to a significant number of leading brands of biologic drugs losing their patents by 2020. “Global Biosimilars Market Regulations & Pipeline Insight” Report Highlights: Market Overview Detailed Regulatory Pathways For 12 Countries/Regions Global Biosimilars Pipeline by Phase, Indication, Company & Country Biosimilars Pipeline ...
September 2014
836 pages
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)
US$ 3,400.00
'GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, ... Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system. ... challenges are identified. In summary, the cancer biomarker and associated companion diagnostic market have ...
April 2014
232 pages
Biomaterials China News 1404 (12 issues per year)
US$ 2,916.00
... of the bio-based chemical fiber industry and its raw materials in China. 2. In recent years, conventional plasticizers have received ... biomass PVA industry and will further devote itself to its development. 8. A new production process developed will effectively lower the production costs of succinic acid ...
April 2014
26 pages
Physician Views – Are physicians getting the biosimilar education they need?
US$ 695.00
... are physicians ready for biosimilars and is the industry doing enough to educate who is arguably the key stakeholder in this market? As physician ... for biosimilar developers and Physician Views: At least some similarity needed in biosimilar naming conventions, say majority of physicians, but caveats remain In a ...
April 2014